15.09.2024, 719 Zeichen

Valneva: Valneva, an Austrian/French specialty vaccine company, issued 23 million new ordinary shares at a price of €2.66 per Offer Share to certain categories of investors via a private placement through an accelerated bookbuilding process starting immediately. The company intends to use the net proceeds of the Private Placement primarily to fund the continuing development of the Company’s clinical programs which include notably the Phase 3 pediatric and Phase 4 programs for the chikungunya vaccine as well as the anticipated Phase 2 programs for the Shigella and Zika vaccine candidates. 
Valneva: weekly performance: -2.53%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (13/09/2024)

Christian Drastil: Wiener Börse Plausch

Börsepeople im Podcast S23/19: Daniel Hahn

Bildnachweis

Aktien auf dem Radar:FACC, UBM, Strabag, Austriacard Holdings AG, Polytec Group, Palfinger, Amag, Rosgix, Bajaj Mobility AG, AT&S, Wienerberger, Lenzing, Telekom Austria, Addiko Bank, Bawag, Erste Group, Gurktaler AG Stamm, Heid AG, RHI Magnesita, BKS Bank Stamm, SW Umwelttechnik, Oberbank AG Stamm, EuroTeleSites AG, Frequentis, CA Immo, EVN, Flughafen Wien, CPI Europe AG, OMV, Österreichische Post, Verbund.

---